<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">11215</article-id><article-id pub-id-type="doi">10.7554/eLife.11215</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Computational and Systems Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Chromosomes and Gene Expression</subject></subj-group></article-categories><title-group><article-title>Methylation of RNA polymerase II non-consensus Lysine residues marks early transcription in mammalian cells</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-42012"><name><surname>Dias</surname><given-names>João D</given-names></name><aff><institution content-type="dept">Epigenetic Regulation and Chromatin Architecture Group, Berlin Institute for Medical Systems Biology</institution>, <institution>Max-Delbrück Centre for Molecular Medicine</institution>, <addr-line><named-content content-type="city">Berlin</named-content></addr-line>, <country>Germany</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-42013"><name><surname>Rito</surname><given-names>Tiago</given-names></name><aff><institution content-type="dept">Epigenetic Regulation and Chromatin Architecture Group, Berlin Institute for Medical Systems Biology</institution>, <institution>Max-Delbrück Centre for Molecular Medicine</institution>, <addr-line><named-content content-type="city">Berlin</named-content></addr-line>, <country>Germany</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-42014"><name><surname>Torlai Triglia</surname><given-names>Elena</given-names></name><aff><institution content-type="dept">Epigenetic Regulation and Chromatin Architecture Group, Berlin Institute for Medical Systems Biology</institution>, <institution>Max-Delbrück Centre for Molecular Medicine</institution>, <addr-line><named-content content-type="city">Berlin</named-content></addr-line>, <country>Germany</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-47601"><name><surname>Kukalev</surname><given-names>Alexander</given-names></name><aff><institution content-type="dept">Epigenetic Regulation and Chromatin Architecture Group, Berlin Institute for Medical Systems Biology</institution>, <institution>Max-Delbrück Centre for Molecular Medicine</institution>, <addr-line><named-content content-type="city">Berlin</named-content></addr-line>, <country>Germany</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-42015"><name><surname>Ferrai</surname><given-names>Carmelo</given-names></name><aff><institution content-type="dept">Epigenetic Regulation and Chromatin Architecture Group, Berlin Institute for Medical Systems Biology</institution>, <institution>Max-Delbrück Centre for Molecular Medicine</institution>, <addr-line><named-content content-type="city">Berlin</named-content></addr-line>, <country>Germany</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-42017"><name><surname>Chotalia</surname><given-names>Mita</given-names></name><aff><institution content-type="dept">Genome Function Group, MRC Clinical Sciences Centre</institution>, <institution>Imperial College London</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-42018"><name><surname>Brookes</surname><given-names>Emily</given-names></name><aff><institution content-type="dept">MRC Laboratory for Molecular and Cell Biology</institution>, <institution>University College London</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-33272"><name><surname>Kimura</surname><given-names>Hiroshi</given-names></name><aff><institution content-type="dept">Graduate School of Bioscience and Biotechnology</institution>, <institution>Tokyo Institute of Technology</institution>, <addr-line><named-content content-type="city">Yokohama</named-content></addr-line>, <country>Japan</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-33361"><name><surname>Pombo</surname><given-names>Ana</given-names></name><aff><institution content-type="dept">Epigenetic Regulation and Chromatin Architecture Group, Berlin Institute for Medical Systems Biology</institution>, <institution>Max-Delbrück Centre for Molecular Medicine</institution>, <addr-line><named-content content-type="city">Berlin</named-content></addr-line>, <country>Germany</country><email>ana.pombo@mdc-berlin.de</email></aff><xref ref-type="fn" rid="conf1"/></contrib></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1166"><name><surname>Proudfoot</surname><given-names>Nick J</given-names></name><role>Reviewing editor</role><aff><institution>University of Oxford</institution>, <country>United Kingdom</country></aff></contrib></contrib-group><pub-date date-type="pub" publication-format="electronic"><day>19</day><month>12</month><year>2015</year></pub-date><volume>4</volume><elocation-id>e11215</elocation-id><supplementary-material><ext-link xlink:href="elife-11215-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material><history><date date-type="received"><day>30</day><month>08</month><year>2015</year></date><date date-type="accepted"><day>18</day><month>12</month><year>2015</year></date></history><permissions><copyright-statement>© 2015, Dias et al</copyright-statement><copyright-year>2015</copyright-year><copyright-holder>Dias et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><abstract><p>Dynamic post-translational modification of RNA polymerase II (RNAPII) coordinates the co-transcriptional recruitment of enzymatic complexes that regulate chromatin states and processing of nascent RNA. Extensive phosphorylation of serine residues at the largest RNAPII subunit occurs at its structurally-disordered C-terminal domain (CTD), which is composed of multiple heptapeptide repeats with consensus sequence Y<sub>1</sub>-S<sub>2</sub>-P<sub>3</sub>-T<sub>4</sub>-S<sub>5</sub>-P<sub>6</sub>-S<sub>7</sub>. Serine-5 and Serine-7 phosphorylation mark transcription initiation, whereas Serine-2 phosphorylation coincides with productive elongation. In vertebrates, the CTD has eight non-canonical substitutions of Serine-7 into Lysine-7, which can be acetylated (K7ac). Here, we describe mono- and di-methylation of CTD Lysine-7 residues (K7me1 and K7me2). K7me1 and K7me2 are observed during the earliest transcription stages and precede or accompany Serine-5 and Serine-7 phosphorylation. In contrast, K7ac is associated with RNAPII elongation, Serine-2 phosphorylation and mRNA expression. We identify an unexpected balance between RNAPII K7 methylation and acetylation at gene promoters, which fine-tunes gene expression levels.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group></article-meta></front><back><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: All handling of mice was approved by the Hokkaido University Animal Experiment Committee (approval number: 11-0109) and carried out according to guidelines for animal experimentation at Hokkaido University, where MAB Institute Inc. is located. Animals were housed in a designated pathogen-free facility at Hokkaido University. Mice were humanely euthanized via cervical dislocation by technically proficient individuals.</p></fn></fn-group></back></article>